Recipient mucosal-associated invariant T cells control GVHD within the colon

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Clinical Investigation

• Publication date

  2018-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI91646PMID 29629900PMCID PMC5919881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The gut microbiota and graft-versus-host disease.

  2019cited by this paper
• Expansion of IL-17A-secreting CD8+ mucosa-associated invariant T cells in peripheral blood following stem cell mobilization.

  2019cited by this paper
• TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions

  2018cited by this paper
• Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation.

  2018cited by this paper
• Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome.

  2017cited by this paper
• Stabilizing short-lived Schiff base derivatives of 5-aminouracils that activate mucosal-associated invariant T cells

  2017cited by this paper
• Human mucosal-associated invariant T cells contribute to antiviral influenza immunity via IL-18–dependent activation

  2016cited by this paper
• Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals

  2016cited by this paper
• Mucosal‐associated invariant T cells in autoimmunity, immune‐mediated diseases and airways disease

  2016cited by this paper
• Gut microbiome derived metabolites modulate intestinal epithelial cell damage and mitigate Graft-versus-Host Disease

  2016cited by this paper
• Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals

  2016cited by this paper
• Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation.

  2016cited by this paper
• MAIT cells are activated during human viral infections

  2016cited by this paper
• Alloantigen presentation and graft-versus-host disease: fuel for the fire.

  2016cited by this paper
• Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases.

  2016cited by this paper
• Recovery of mucosal-associated invariant T cells after myeloablative chemotherapy and autologous peripheral blood stem cell transplantation

  2016cited by this paper
• Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation.

  2015cited by this paper
• Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects.

  2015cited by this paper
• Mucosal-Associated Invariant T Cells in Inflammatory Bowel Diseases: Bystanders, Defenders, or Offenders?

  2015cited by this paper
• Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability.

  2015cited by this paper
• Donor colonic CD103+ dendritic cells determine the severity of acute graft-versus-host disease

  2015cited by this paper
• Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations

  2015cited by this paper
• Recognition of Vitamin B Precursors and Byproducts by Mucosal Associated Invariant T Cells*

  2015cited by this paper
• Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites

  2015cited by this paper
• The burgeoning family of unconventional T cells

  2015cited by this paper
• Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation.

  2015cited by this paper
• Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers

  2015cited by this paper
• Growth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage.

  2015cited by this paper
• IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells.

  2014cited by this paper
• The biology of graft-versus-host disease: experimental systems instructing clinical practice.

  2014cited by this paper
• T-cell activation by transitory neo-antigens derived from distinct microbial pathways

  2014cited by this paper
• Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens

  2014cited by this paper
• Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

  2013cited by this paper
• Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells

  2013cited by this paper
• Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation

  2013cited by this paper
• Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

  2013cited by this paper
• MAIT cells, surveyors of a new class of antigen: development and functions.

  2013cited by this paper
• MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection

  2013cited by this paper
• Recognition of vitamin B metabolites by mucosal-associated invariant T cells

  2013cited by this paper
• Double Positive Thymocytes Select Mucosal-Associated Invariant T Cells

  2013cited by this paper
• CD161++CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner

  2013cited by this paper
• Co-dependents: MR1-restricted MAIT cells and their antimicrobial function

  2012cited by this paper
• Functionally relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice

  2012cited by this paper
• Polyclonal Mucosa-Associated Invariant T Cells Have Unique Innate Functions in Bacterial Infection

  2012cited by this paper
• MR1 presents microbial vitamin B metabolites to MAIT cells

  2012cited by this paper
• Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.

  2012cited by this paper
• Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis.

  2012cited by this paper
• Identification of Semaphorin 4B as a Negative Regulator of Basophil-Mediated Immune Responses

  2011cited by this paper
• First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

  2011cited by this paper
• The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice.

  2011cited by this paper
• Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species

  2011cited by this paper
• Fate mapping of interleukin 17-producing T cells in inflammatory responses

  2011cited by this paper
• Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells.

  2011cited by this paper
• Innate IL-17-producing cells: the sentinels of the immune system

  2010cited by this paper
• Antimicrobial activity of mucosal-associated invariant T cells

  2010cited by this paper
• QIIME allows analysis of high-throughput community sequencing data

  2010cited by this paper
• Fighting infection with your MAITs

  2010cited by this paper
• Altered production of immunoregulatory cytokines by invariant Valpha19 TCR-bearing cells dependent on the duration and intensity of TCR engagement.

  2009cited by this paper
• IL-17 contributes to CD4-mediated graft-versus-host disease.

  2009cited by this paper
• Stepwise Development of MAIT Cells in Mouse and Human

  2009cited by this paper
• Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses.

  2009cited by this paper
• Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells.

  2009cited by this paper
• Regulatory T cells reinforce intestinal homeostasis.

  2009cited by this paper
• A protective function for interleukin 17A in T cell–mediated intestinal inflammation

  2009cited by this paper
• Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administration.

  2009cited by this paper
• IL-17 produced by Paneth cells drives TNF-induced shock

  2008cited by this paper
• Induction and effector functions of TH17 cells

  2008cited by this paper
• Semaphorin 6D regulates the late phase of CD4+ T cell primary immune responses

  2008cited by this paper
• Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut

  2008cited by this paper
• The biological functions of T helper 17 cell effector cytokines in inflammation.

  2008cited by this paper
• Invariant Vα19i T cells regulate autoimmune inflammation

  2006cited by this paper
• Invariant V(alpha)19i T cells regulate autoimmune inflammation.

  2006cited by this paper
• MR1-Restricted Vα19i Mucosal-Associated Invariant T Cells Are Innate T Cells in the Gut Lamina Propria That Provide a Rapid and Diverse Cytokine Response1

  2006cited by this paper
• Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

  2006cited by this paper
• In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets.

  2005cited by this paper
• Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.

  2004cited by this paper
• IL-4 selectively enhances FcγRIII expression and signaling on mouse mast cells ☆

  2003cited by this paper
• IL-4 selectively enhances FcgammaRIII expression and signaling on mouse mast cells.

  2003cited by this paper
• Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1

  2003cited by this paper
• The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.

  2000cited by this paper
• γ chain required for naïve CD4+ T cell survival but not for antigen proliferation

  2000cited by this paper
• An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin.

  1996cited by this paper
• Basic local alignment search tool.

  1990cited by this paper

• Mucosal‐Associated Invariant T Cells: Origins, Biological Functions, Diseases, and Therapeutic Targets

  2025cites this paper
• Single-cell RNA sequencing reveals heterogeneity of mucosa-associated invariant T cells in donor grafts and its diagnostic relevance in gastrointestinal graft-versus-host disease

  2025cites this paper
• Circulating mucosa-associated invariant T cells are decreased and have impaired function in patients with diffuse large B-cell lymphoma

  2025cites this paper
• Biological functions and therapeutic applications of human mucosal-associated invariant T cells

  2025cites this paper
• Defenders or defectors: mucosal-associated invariant T cells in autoimmune diseases.

  2025cites this paper
• MAIT cells protect against sterile lung injury

  2025cites this paper
• Development and Functions of MAIT Cells.

  2025cites this paper
• MAIT cells modulating the oral lichen planus immune microenvironment: a cellular crosstalk perspective

  2025cites this paper
• Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions

  2025cites this paper
• Macrophage MR1 antigen presentation promotes MAIT cell immunity and lung microbiota modulation.

  2025cites this paper
• Mucosal-associated invariant T cells and the gut–kidney axis: a review

  2025cites this paper
• Immune mediators as therapeutic targets in GvHD; cytokines, growth factors, chemokines, and co-stimulation /co-inhibition.

  2025cites this paper
• Gut microbiota and acute graft-versus-host disease.

  2025cites this paper
• Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell Transplantation

  2024cites this paper
• Mucosal-associated invariant T cells are functionally impaired in pediatric and young adult patients following allogeneic hematopoietic stem cell transplantation and their recovery correlates with clinical outcomes

  2024cites this paper
• Mucosal-associated invariant T cells promote ductular reaction through amphiregulin in biliary atresia

  2024cites this paper
• CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy

  2024influential citation
• Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models

  2024cites this paper
• Human MAIT cells inhibit alloreactive T cell responses and protect against acute graft-versus-host disease

  2024cites this paper
• MAIT cells: Conserved watchers on the wall

  2024cites this paper
• Insights into the tissue repair features of MAIT cells

  2024influential citation
• MAIT cells monitor intestinal dysbiosis and contribute to host protection during colitis

  2024cites this paper
• Role of MAIT cells in gastrointestinal tract bacterial infections in humans: more than a gut feeling.

  2023cites this paper
• Graft-versus-Host Disease Modulation by Innate T Cells

  2023cites this paper
• Mucosal‐associated invariant T cells in digestive tract: Local guardians or destroyers?

  2023cites this paper
• Mucosal-associated invariant T cells in hematological malignancies: Current knowledge, pending questions

  2023cites this paper
• MAIT cells and the microbiome

  2023influential citation
• Mucosal-associated invariant T cells display both pathogenic and protective roles in patients with inflammatory bowel diseases

  2023cites this paper
• MR1 antigen presentation to MAIT cells and other MR1-restricted T cells

  2023cites this paper
• Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging

  2023cites this paper
• The contribution of the intestinal microbiome to immune recovery after HCT

  2022influential citation
• GVHD, IBD, and primary immunodeficiencies: The gut as a target of immunopathology resulting from impaired immunity

  2022cites this paper
• MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT

  2022cites this paper
• Efflux capacity and aldehyde dehydrogenase both contribute to CD8+ T-cell resistance to posttransplant cyclophosphamide

  2022cites this paper
• Inflammation in obesity, diabetes, and related disorders.

  2022cites this paper
• Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols

  2022cites this paper
• Mucosal-associated invariant T cells for cancer immunotherapy

  2022influential citation
• Mining the multifunction of mucosal-associated invariant T cells in hematological malignancies and transplantation immunity: A promising hexagon soldier in immunomodulatory

  2022cites this paper
• Chemical Modulators of Mucosal Associated Invariant T Cells.

  2021cites this paper
• Advances in Host-Directed Therapies Against Tuberculosis

  2021cites this paper
• The role of the thymus in allogeneic bone marrow transplantation and the recovery of the peripheral T-cell compartment

  2021cites this paper
• Current Concepts and Advances in Graft-Versus-Host Disease Immunology.

  2021influential citation
• The burgeoning role of MR1-restricted T-cells in infection, cancer and autoimmune disease.

  2021cites this paper
• Associations between the Gut Microbiota, Immune Reconstitution, and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation

  2021cites this paper
• Microbiome-Derived Metabolites in Allogeneic Hematopoietic Stem Cell Transplantation

  2021cites this paper
• An Unconventional View of T Cell Reconstitution After Allogeneic Hematopoietic Cell Transplantation

  2021cites this paper
• Alcohol-Associated Intestinal Dysbiosis Alters Mucosal-Associated Invariant T-Cell Phenotype and Function.

  2021cites this paper
• MAIT cells, guardians of skin and mucosa?

  2021cites this paper
• Innate (and Innate-like) Lymphoid Cells: Emerging Immune Subsets With Multiple Roles Along Transplant Life

  2021cites this paper
• Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy

  2021cites this paper
• IFNλ Therapy Prevents Severe Gastrointestinal Graft-versus-Host Disease.

  2021cites this paper
• iPSC-derived mucosal-associated invariant T cells

  2021cites this paper
• Emerging concepts in intestinal immune control of obesity-related metabolic disease

  2021cites this paper
• Prolonged suppression of butyrate producing bacteria is associated with acute gastrointestinal graft-versus-host disease and transplant related mortality after allogeneic stem cell transplantation.

  2021cites this paper
• IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease

  2021cites this paper
• Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel Disease

  2021cites this paper
• Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation

  2021cites this paper
• The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation

  2021cites this paper
• Characteristics of mucosal-associated invariant T cells and their roles in immune diseases.

  2021cites this paper
• Immune Suppression in Allogeneic Hematopoietic Stem Cell Transplantation.

  2021cites this paper
• Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease

  2021cites this paper
• Impaired CD8+ Mucosal-Associated Invariant T Cells and Myeloid-Derived Suppressor Cells Promote The Development of Polycystic Ovary Syndrome

  2021cites this paper
• Roles of the intestinal microbiota and microbial metabolites in acute GVHD

  2021cites this paper
• Involvement of impaired CD8+ mucosal-associated invariant T cells and myeloid-derived suppressor cells in polycystic ovary syndrome

  2021cites this paper
• MAIT cell activation augments adenovirus vector vaccine immunogenicity

  2020cites this paper
• The Immune Modulating Properties of Mucosal-Associated Invariant T Cells

  2020cites this paper
• Mucosal‐associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy‐related colitis in a pathology distinct from ulcerative colitis

  2020cites this paper
• MR1: a multi-faceted metabolite sensor for T cell activation.

  2020cites this paper
• Cytokines and Co-stimulation in Acute Graft-versus-Host Disease.

  2020cites this paper
• Mucosal associated invariant T cells are differentially impaired in tolerant and immunosuppressed liver transplant recipients

  2020cites this paper
• MR1-Restricted T Cells Are Unprecedented Cancer Fighters

  2020cites this paper
• MAIT Cells Come to the Rescue in Cancer Immunotherapy?

  2020cites this paper
• Reconstitution of Circulating Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation: Its Association with the Riboflavin Synthetic Pathway of Gut Microbiota in Cord Blood Transplant Recipients

  2020cites this paper
• MAIT Cells in Health and Disease.

  2020influential citation
• Continuous pre- and post-transplant exposure to a disease-associated gut microbiome promotes hyper-acute graft-versus-host disease in wild-type mice

  2020cites this paper
• Emerging Role for MAIT Cells in Control of Antimicrobial Resistance.

  2020cites this paper
• Mouse models illuminate MAIT cell biology.

  2020cites this paper
• H. Mucosal-Associated Invariant and Vγ9Vδ2 T Cells

  2020cites this paper
• MAIT Cells in Barrier Tissues: Lessons from Immediate Neighbors

  2020influential citation
• MR1-restricted T cells: the new dawn of cancer immunotherapy

  2020cites this paper
• Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries

  2020cites this paper
• MAIT Cells at the Fetal-Maternal Interface During Pregnancy

  2020cites this paper
• Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD

  2019cites this paper
• MAIT Cells in Health and Disease.

  2019cites this paper
• Computer modelling and synthesis of deoxy and monohydroxy analogues of a ribitylaminouracil bacterial metabolite that potently activates human T cells.

  2019cites this paper
• Microbial metabolites control the thymic development of mucosal-associated invariant T cells

  2019cites this paper
• The biology and functional importance of MAIT cells

  2019cites this paper
• Mucosal-associated invariant T cells and disease

  2019cites this paper
• The gut microbiota and graft-versus-host disease.

  2019cites this paper
• Cytokines in GVHD and GVL

  2019cites this paper
• Expansion of IL-17A-secreting CD8+ mucosa-associated invariant T cells in peripheral blood following stem cell mobilization.

  2019cites this paper
• MAIT cells promote tumor initiation, growth and metastases via tumor MR1.

  2019cites this paper
• The Conventional Nature of Non-MHC-Restricted T Cells

  2018influential citation
• TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions

  2018cites this paper
• MicroRNA miR‐181a/b‐1 controls MAIT cell development

  2018cites this paper
• Revealing the protective and pathogenic potential of MAIT cells.

  2018cites this paper
• Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections

  2018cites this paper
• An overview on the identification of MAIT cell antigens

  2018cites this paper